AzTrials
AzTrials

Hand Foot and Mouth Disease08RSNCT02066714

Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in Vietnam

An observational study of Hand Foot and Mouth Disease, run by Oxford University Clinical Research Unit, Vietnam at 1 site in Vietnam.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hand Foot and Mouth Disease (HFMD) is a common infectious disease in childhood. Several enteroviruses are associated with the disease. However, since 1997, large outbreaks of HFMD in Taiwan, Malaysia and Vietnam have seen unusual neurological complications such as brainstem encephalitis with rare fatal outcomes. Read more about this study

Who is it for?
Ages Up to 4 yearsHealthy volunteers can take part
Conditions the study is for
Hand Foot and Mouth Disease
How many people
243 participants
Where
1 siteVietnam
Study dates
Jun 2013to Aug 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 4 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Hand foot and mouth disease patients admitted to Hospital of Tropical Diseases. Healthy children form 3 kindergartens in District 8, HCMC and infants enrolled in Dengue Birth cohort (Oxtrec 02-09)

Who may be able to join

  • Hospitalized children ≤ 4 years admitted with HFMD at Hospital for Tropical Diseases (HTD)
  • Parents or legal guardians must give informed consent for their child to participate.
  • Child age ≤ 4 years
  • Parents or legal guardians must give informed consent for their child to participate.

Who cannot join

  • Ex-premature children
  • Any prior chronic illness whether required hospitalization or not
  • Previous Pediatric Intensive Care Unit (PICU) admission/ventilation including during neonatal period
  • Prior learning disability or neurological regression
  • Healthy cohort
  • Ex-premature children
Show all 9Show fewer
  • Any prior chronic illness whether required hospitalization or not
  • Previous PICU admission/ventilation including during neonatal period
  • Prior learning disability or neurological regression

Trial locations and contacts

1 site in 1 country.

Vietnam1 site
  • Hospital of Tropical Diseases

    Ho Chi Minh City

Other trials in Vietnam

About this study

Official title: A Prospective Cohort Study Evaluating Prognostic Indicators and Sequelae Following Severe Hand Foot and Mouth Disease

Hand Foot and Mouth Disease (HFMD) is a common infectious disease in childhood. Several enteroviruses are associated with the disease. However, since 1997, large outbreaks of HFMD in Taiwan, Malaysia and Vietnam have seen unusual neurological complications such as brainstem encephalitis with rare fatal outcomes. The pathogen associated with this severe disease is Enterovirus 71.

In 2011, Vietnam had a large outbreak of Hand Foot and mouth disease resulting in 110,000 cases and 164 deaths. HFMD affects children during their early years of child development, but there is limited information on what the potential long-term consequences are. Small studies have suggested language and cognitive difficulties in more severe disease but this has not been evaluated in a large cohort.

Read more

Internationally recognized and standardized assessment tools are not available for early childhood in Vietnam. This project will translate and adapt the Bayley Scales of Toddler and Infant Development 3rd edition (Bayley III) and Movement ABC, 2nd edition (MABC) into Vietnamese as outcome measures.

This study will evaluate whether there are neurodevelopment difficulties following severe HFMD. The study design is a prospective observational cohort study. Hospitalised children with a clinical diagnosis of HFMD will be eligible to enroll. Written parental consent will be required. Participants enrolled will be assessed 3 times over 18 months from discharge from hospital into the study. Since there is no standardization of Bayley III or MABC for Vietnam, a healthy cohort, age and sex matched to the least severe HFMD participants will be recruited. This healthy cohort will follow the same assessment program over 18 months. A total of 350 HFMD participants and 150 healthy children (matched to the least severe HFMD participants) will be recruited.

Read the detailed description

Background:

Hand foot and mouth disease outbreaks associated with enterovirus 71 (EV71) were unusual in their neurological manifestations. Since 1997, Taiwan, Malaysia and Vietnam have experienced large outbreaks of EV71-HFMD.

Neurological manifestations include meningitis, brainstem encephalitis, and rare cardiopulmonary failure, thought to be neurogenic in origin.

In Vietnam, children are admitted to hospital if they show signs of systemic disease. The Vietnam Ministry of Health has developed a grading system to stratify management and intervention. Grade 1 have solely the typical rash on palms of hands, soles on feet and buttock with ulcers in the mouth. Grade 2 have systemic features such has high fever, irritability and myoclonus. Grade 2 is split into 2a for parental report of symptoms or 2b if a health professional has observed neurological signs. Grade 2 onwards are admitted to hospital. Grade 3 develop irregular breathing, persistent tachycardia, hypertension, all features of autonomic disturbance due to brainstem encephalitis. Grade 4 develop often fatal cardiopulmonary failure, believed to be a consequence of excessive unopposed sympathetic activation from brainstem disease.

Different countries use different grading or staging systems for HFMD. A study in 142 EV71 suggested children affected at a younger age of onset of disease might have consequences for verbal comprehension. In 63 children with EV71 disease, 14% had cognitive or motor deficits.

Hypothesis and Aims:

The study aims to identify the neurological and neurodevelopmental outcomes following severe (hospitalised) HFMD in Vietnam.

Study Design:

Prospective observational cohort study. There are two cohorts in this study. The HFMD participants and healthy children. All children hospitalized with HFMD are eligible for participation. From preliminary review of admissions to the hospital, we identified the majority of patients were admitted from a local district in Ho Chi Minh City (HCMC) (District 8). All participants will be asked if they agree for an optional brain magnetic resonance imaging (MRI).

We will approach kindergartens in that district to enroll healthy children, and also approach participants in another Oxford University Clinical Research Unit, HCMC study run at a local obstetric hospital to enroll healthy infants. This healthy cohort will be age and sex matched to the least severe grade of HFMD participants.

HFMD will have neurological and neurodevelopmental assessments carried out 1 week after discharge, 6 months later and the last assessment 18 months after the initial assessment. The Healthy cohort will have a neurodevelopmental assessment at enrollment. 6 months and 18 months after the initial assessment.

Primary Outcomes

  1. Comparison of neurodevelopment scores at discharge, at 6 and at 18 months of follow up between least severe HFMD children and an age and sex matched healthy comparison cohort.
  2. Comparison of neurodevelopment scores at 1 week after discharge, at 6 and at 18 months after discharge between children stratified by HFMD disease grade.

Other Outcomes

  1. Descriptive Brain MRI Changes according to severity of HFMD

Sample size and analysis plan:

We aim to include up to 350 children with HFMD grade 2a, 2b, 3 and 4, and 150 healthy children (matched for Grade 2a) and follow them up at enrolment, 6 and 18 months of follow-up.

The Bayley scoring system has a mean score of 100 with a standard deviation (SD) of 15 in healthy American children. Based on this, we assume an SD of approximately 15 in all 5 study populations. As little is known about within-child longitudinal changes in Bailey scores over time, power considerations are based on pair-wise comparisons between groups at each time point separately. With the sample sizes given, we will have 80% power at the two-sided 5% significance level to detect differences in mean scores of - 7.4 or larger between grade 2a or 2b children compared to grade 3 or 4 children, respectively.

Statistical Methods Standard data summaries such as median (inter-quartile range) for continuous variables and frequency (%) for categorical variable together with graphical summaries (histograms, box plots and scatterplots) will be used for descriptive analyses in all studies.

Longitudinal profiles of development scores over time will be visualized by line plots of individual subjects' data with overlaid smoothed lines for average development scores over time within groups. Modeling of longitudinal profiles over time and group comparisons will be based on standard methods for longitudinal data analysis such as linear mixed effects models.

Potential Impact:

To public health implications of HFMD require evaluation of long-term. If the burden of disease continues to have a neurological impact on a significant proportion of children, a vaccine-based approach is essential and cost-effective.

As intense efforts are underway in vaccine development, research is essential in helping clinicians on the front line to identify the minority of children who may progress and focus limited resources appropriately.

Keywords
Enterovirus Infections, Hand, Foot and Mouth Disease, Coxsackievirus Infections, Herpangina, Cognition, Neurocognitive, Sequelae, Outcomes
Medical subject headings
Hand, Foot and Mouth Disease, Enterovirus Infections, Coxsackievirus Infections, Herpangina

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02066714
Study groupRoleWhat they receive
Healthy CohortThese children will be recruited from district 8, Ho Chi Minh City where most HFMD admissions to the Hospital for Tropical Diseases occur. We wil recruit healthy children from three kindergartens and ask for volunteers from participants enrolled in an Oxford University Clinical Research Unit Dengue birth cohort study (OXTREC approval 02-09) in District 8, HCMC. This birth cohort is an observational study.
Hand Foot and Mouth DiseaseThe Vietnamese Ministry of Health has a clinical grading system. Grade 1 disease is uncomplicated and are not admitted to hospital. Grade 2 and above are admitted to hospital with clinical features of neurological or systemic involvement. Grade 2 is split into Grade 2a and 2b depending if neurological manifestations such as myoclonus have been witnessed by the parents or by a health professional. In total, it is anticipated that 125 Grade 2a and 125 Grade 2b and 100 more severe Grade 3 and 4 will be recruited over one year. A subset who agree for brain magnetic resonance imaging (MRI) will also have a scan done during their hospital admission.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive, language and motor development

    Measured by: Children 36 months and under at enrollment will use the translated and adapted Bayley Scales of Toddler and Infant Development 3rd Edition (Bayley III) for Vietnam. Children 48 months and above at enrollment will use the Vietnamese translation of Movement ABC-2 tool for their assessments. The children aged between 37 and 47 months at enrolment will have both assessments done at both visits.

    Measured: 18 months post discharge

Secondary outcomes (1)
  1. Neurological status

    Amiel-Tison Standardised neurological examination 0-6 years

    Measured: 18 months post discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2014 (estimated)
  2. Study startJun 2013
  3. Primary completionDec 2014
  4. Study completionAug 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
243 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02066714
Sponsor's protocol ID
08RS
Acronym
08RS
Status last verified
Oct 2016
First submitted
14 Feb 2014
Last updated
4 Oct 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hand Foot and Mouth Disease, run by Oxford University Clinical Research Unit, Vietnam at 1 site in Vietnam.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive, language and motor development (time frame: 18 months post discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in